Furthermore, the IFN-γ signature genes which were highly expressed in M-subtype OSCC were found to be significantly associated with survival with R/M-HNSCC in the KEYNOTE-040 trial. The gene discussed is IFNG; the disease is head and neck squamous cell carcinoma.